Light Mode
$16.75 ↑ +1.35 (+8.78%) Trading Up from the previous close of $15.40, and at the day’s high of $16.75
+2.33 (+16.13%) / 6M
Momentum, market sentiment, and recent alerts
KYKOF reads very good: the 12-month move is +4.1%.
No alerts for KYKOF in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.